Cardlytics, Inc.
US ˙ NasdaqGM ˙ US14161W1053

SecurityCDLX / Cardlytics, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
D. E. Shaw & Co., Inc. ownership in CDLX / Cardlytics, Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 0 shares of Cardlytics, Inc. (US:CDLX) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 26,206 shares of Cardlytics, Inc.. The current value of the position is $0 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (CDLX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CDLX / Cardlytics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CARDLYTICS COM 14161W105 0 -100.00 0
2026-02-17 2025-12-31 13F CARDLYTICS COM 14161W105 26,206 -64,872 -71.23 30 -86.43 0.0000
2025-11-14 2025-09-30 13F CARDLYTICS COM 14161W105 91,078 -413,872 -81.96 221 -73.37 0.0001
2025-08-14 2025-06-30 13F CARDLYTICS COM 14161W105 504,950 -356,661 -41.39 831 -47.07 0.0006
2025-05-15 2025-03-31 13F CARDLYTICS COM 14161W105 861,611 -269,894 -23.85 1,568 -62.64 0.0014
2025-02-14 2024-12-31 13F CARDLYTICS COM 14161W105 1,131,505 558,235 97.38 4,198 128.84 0.0031
2024-11-14 2024-09-30 13F CARDLYTICS COM 14161W105 573,270 484,361 544.78 1,834 151.58 0.0016
2024-08-14 2024-06-30 13F CARDLYTICS COM 14161W105 88,909 -415,424 -82.37 730 -90.02 0.0007
2024-05-15 2024-03-31 13F CARDLYTICS COM 14161W105 504,333 -142,473 -22.03 7,308 22.66 0.0063
2024-02-14 2023-12-31 13F CARDLYTICS COM 14161W105 646,806 -56,137 -7.99 5,957 -48.64 0.0052
2023-11-14 2023-09-30 13F CARDLYTICS COM 14161W105 702,943 -333,690 -32.19 11,599 77.04 0.0121
2023-08-14 2023-06-30 13F CARDLYTICS COM 14161W105 1,036,633 -87,595 -7.79 6,552 71.67 0.0067
2023-05-15 2023-03-31 13F CARDLYTICS COM 14161W105 1,124,228 -151,255 -11.86 3,817 -48.24 0.0041
2023-02-14 2022-12-31 13F CARDLYTICS COM 14161W105 1,275,483 1,060,670 493.76 7,372 265.13 0.0081
2022-11-14 2022-09-30 13F CARDLYTICS COM 14161W105 214,813 108,938 102.89 2,019 -14.52 0.0024
2022-08-15 2022-06-30 13F CARDLYTICS COM 14161W105 105,875 96,218 996.35 2,362 344.82 0.0028
2022-05-16 2022-03-31 13F CARDLYTICS COM 14161W105 9,657 -12,802 -57.00 531 -64.22 0.0005
2022-02-14 2021-12-31 13F CARDLYTICS COM 14161W105 22,459 17,701 372.03 1,484 271.93 0.0012
2021-11-15 2021-09-30 13F CARDLYTICS COM 14161W105 4,758 -300 -5.93 399 -37.85 0.0004
2021-08-16 2021-06-30 13F CARDLYTICS COM 14161W105 5,058 -43,008 -89.48 642 -87.82 0.0006
2021-05-17 2021-03-31 13F CARDLYTICS COM 14161W105 48,066 12,870 36.57 5,273 4.94 0.0051
2021-02-16 2020-12-31 13F CARDLYTICS COM 14161W105 35,196 -46,421 -56.88 5,025 -12.76 0.0045
2020-11-16 2020-09-30 13F CARDLYTICS COM 14161W105 81,617 29,646 57.04 5,760 58.37 0.0059
2020-08-14 2020-06-30 13F CARDLYTICS COM 14161W105 51,971 -53,203 -50.59 3,637 -1.09 0.0043
2020-05-15 2020-03-31 13F CARDLYTICS COM 14161W105 105,174 -301,852 -74.16 3,677 -85.63 0.0057
2020-02-14 2019-12-31 13F CARDLYTICS COM 14161W105 407,026 407,026 25,586 0.0293
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-08-14 2023-06-30 13F CARDLYTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F CARDLYTICS COM Call 17,100 -88.12 58 -93.02 n/a n/a n/a
2023-02-14 2022-12-31 13F CARDLYTICS COM Call 143,900 -18.38 832 -49.85 n/a n/a n/a
2022-11-14 2022-09-30 13F CARDLYTICS COM Call 176,300 338.56 1,657 84.73 n/a n/a n/a
2022-08-15 2022-06-30 13F CARDLYTICS COM Call 40,200 897 n/a n/a n/a
2021-08-16 2021-06-30 13F CARDLYTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F CARDLYTICS COM Call 5,500 603 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-11-14 2022-09-30 13F CARDLYTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F CARDLYTICS COM Put 30,200 674 n/a n/a n/a
2021-08-16 2021-06-30 13F CARDLYTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F CARDLYTICS COM Put 10,000 104.08 1,097 56.71 n/a n/a n/a
2021-02-16 2020-12-31 13F CARDLYTICS COM Put 4,900 0.00 700 102.31 n/a n/a n/a
2020-11-16 2020-09-30 13F CARDLYTICS COM Put 4,900 0.00 346 0.87 n/a n/a n/a
2020-08-14 2020-06-30 13F CARDLYTICS COM Put 4,900 343 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.